Literature DB >> 19357247

Delta receptors are required for full inhibitory coupling of mu-receptors to voltage-dependent Ca(2+) channels in dorsal root ganglion neurons.

Wendy Walwyn1, Scott John, Matthew Maga, Christopher J Evans, Tim G Hales.   

Abstract

Recombinant micro and delta opioid receptors expressed in cell lines can form heterodimers with distinctive properties and trafficking. However, a role for opioid receptor heterodimerization in neurons has yet to be identified. The inhibitory coupling of opioid receptors to voltage-dependent Ca(2+) channels (VDCCs) is a relatively inefficient process and therefore provides a sensitive assay of altered opioid receptor function and expression. We examined micro-receptor coupling to VDCCs in dorsal root ganglion neurons of delta(+/+), delta(+/-), and delta(-/-) mice. Neurons deficient in delta receptors exhibited reduced inhibition of VDCCs by morphine and [D-Ala(2),Phe(4),Gly(5)-ol]-enkephalin (DAMGO). An absence of delta receptors caused reduced efficacy of DAMGO without affecting potency. An absence of delta receptors reduced neither the density of VDCCs nor their inhibition by either the GABA(B) receptor agonist baclofen or intracellular guanosine 5'-O-(3-thio)triphosphate. Flow cytometry revealed a reduction in micro-receptor surface expression in delta(-/-) neurons without altered DAMGO-induced internalization. There was no change in micro-receptor mRNA levels. D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH(2)-sensitive mu-receptor-coupling efficacy was fully restored to delta(+/+) levels in delta(-/-) neurons by expression of recombinant delta receptors. However, the dimerization-deficient delta-15 construct expressed in delta(-/-) neurons failed to fully restore the inhibitory coupling of micro-receptors compared with that seen in delta(+/+) neurons, suggesting that, although not essential for micro-receptor function, micro-delta receptor dimerization contributes to full micro-agonist efficacy. Because DAMGO exhibited a similar potency in delta(+/+) and delta(-/-) neurons and caused similar levels of internalization, the role for heterodimerization is probably at the level of receptor biosynthesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19357247      PMCID: PMC2701458          DOI: 10.1124/mol.109.055913

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  44 in total

Review 1.  Cellular and synaptic adaptations mediating opioid dependence.

Authors:  J T Williams; M J Christie; O Manzoni
Journal:  Physiol Rev       Date:  2001-01       Impact factor: 37.312

2.  Identification of G protein-coupled receptor kinase 2 phosphorylation sites responsible for agonist-stimulated delta-opioid receptor phosphorylation.

Authors:  J Guo; Y Wu; W Zhang; J Zhao; L A Devi; G Pei; L Ma
Journal:  Mol Pharmacol       Date:  2000-11       Impact factor: 4.436

3.  A trafficking checkpoint controls GABA(B) receptor heterodimerization.

Authors:  M Margeta-Mitrovic; Y N Jan; L Y Jan
Journal:  Neuron       Date:  2000-07       Impact factor: 17.173

Review 4.  Chemical structures and biological activities of non-peptide selective kappa opioid ligands.

Authors:  D C Rees
Journal:  Prog Med Chem       Date:  1992

5.  Receptor heterodimerization leads to a switch in signaling: beta-arrestin2-mediated ERK activation by mu-delta opioid receptor heterodimers.

Authors:  Raphael Rozenfeld; Lakshmi A Devi
Journal:  FASEB J       Date:  2007-03-23       Impact factor: 5.191

6.  Coexpression of delta-opioid receptors with micro receptors in GH3 cells changes the functional response to micro agonists from inhibitory to excitatory.

Authors:  Andrew C Charles; Natalya Mostovskaya; Kathleen Asas; Christopher J Evans; Megan L Dankovich; Tim G Hales
Journal:  Mol Pharmacol       Date:  2003-01       Impact factor: 4.436

7.  Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal.

Authors:  F Simonin; O Valverde; C Smadja; S Slowe; I Kitchen; A Dierich; M Le Meur; B P Roques; R Maldonado; B L Kieffer
Journal:  EMBO J       Date:  1998-02-16       Impact factor: 11.598

8.  Functional coupling, desensitization and internalization of virally expressed mu opioid receptors in cultured dorsal root ganglion neurons from mu opioid receptor knockout mice.

Authors:  W M Walwyn; D E Keith; W Wei; A M Tan; C W Xie; C J Evans; B L Kieffer; N T Maidment
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

9.  Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis.

Authors:  Sonia Terrillon; Thierry Durroux; Bernard Mouillac; Andreas Breit; Mohammed A Ayoub; Magali Taulan; Ralf Jockers; Claude Barberis; Michel Bouvier
Journal:  Mol Endocrinol       Date:  2002-12-23

Review 10.  Opioid receptor genes inactivated in mice: the highlights.

Authors:  C Gavériaux-Ruff; B L Kieffer
Journal:  Neuropeptides       Date:  2002 Apr-Jun       Impact factor: 3.286

View more
  17 in total

1.  μ opioid receptor activation hyperpolarizes respiratory-controlling Kölliker-Fuse neurons and suppresses post-inspiratory drive.

Authors:  Erica S Levitt; Ana P Abdala; Julian F R Paton; John M Bissonnette; John T Williams
Journal:  J Physiol       Date:  2015-08-19       Impact factor: 5.182

Review 2.  Recent advances on the δ opioid receptor: from trafficking to function.

Authors:  Louis Gendron; Nitish Mittal; Hélène Beaudry; Wendy Walwyn
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 3.  In vivo opioid receptor heteromerization: where do we stand?

Authors:  D Massotte
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

4.  Mu and delta opioid receptors on nociceptors attenuate mechanical hyperalgesia in rat.

Authors:  E K Joseph; J D Levine
Journal:  Neuroscience       Date:  2010-08-22       Impact factor: 3.590

5.  Alteration of the mu opioid receptor: Ca2+ channel signaling pathway in a subset of rat sensory neurons following chronic femoral artery occlusion.

Authors:  Bassil Hassan; Joyce S Kim; Mohamed Farrag; Marc P Kaufman; Victor Ruiz-Velasco
Journal:  J Neurophysiol       Date:  2014-09-17       Impact factor: 2.714

Review 6.  Opioid receptor heteromers in analgesia.

Authors:  Cristina M Costantino; Ivone Gomes; Steven D Stockton; Maribel P Lim; Lakshmi A Devi
Journal:  Expert Rev Mol Med       Date:  2012-04-10       Impact factor: 5.600

7.  Select G-protein-coupled receptors modulate agonist-induced signaling via a ROCK, LIMK, and β-arrestin 1 pathway.

Authors:  Nitish Mittal; Kristofer Roberts; Katsuri Pal; Laurent A Bentolila; Elissa Fultz; Ani Minasyan; Catherine Cahill; Amynah Pradhan; David Conner; Kathryn DeFea; Christopher Evans; Wendy Walwyn
Journal:  Cell Rep       Date:  2013-11-14       Impact factor: 9.423

8.  Differential pharmacological actions of methadone and buprenorphine in human embryonic kidney 293 cells coexpressing human μ-opioid and opioid receptor-like 1 receptors.

Authors:  Cynthia Wei-Sheng Lee; Jia-Ying Yan; Yao-Chang Chiang; Tsai-Wei Hung; Hung-Li Wang; Lih-Chu Chiou; Ing-Kang Ho
Journal:  Neurochem Res       Date:  2011-06-14       Impact factor: 3.996

9.  Chronic inflammatory injury results in increased coupling of delta opioid receptors to voltage-gated Ca2+ channels.

Authors:  Amynah Pradhan; Monique Smith; Brenna McGuire; Christopher Evans; Wendy Walwyn
Journal:  Mol Pain       Date:  2013-03-04       Impact factor: 3.395

10.  Pharmacological Profiles of Oligomerized μ-Opioid Receptors.

Authors:  Cynthia Wei-Sheng Lee; Ing-Kang Ho
Journal:  Cells       Date:  2013-10-11       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.